
A pediatric formulation of ViiV’s HIV medication Dovato has been submitted to the FDA and European regulators for review. If approved, this version of the two-drug once-daily regimen could be used as treatment for children as young as 3 months old.
positivelyaware.com/dovato-pediatr…

English



















